Production (Stage)
Theratechnologies Inc.
TH.TO
TSX
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -30.91% | 79.39% | 65.33% | 89.16% | 80.53% |
| Total Depreciation and Amortization | -39.62% | -5.46% | -16.71% | -22.70% | -12.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 374.14% | 261.34% | 89.45% | -2.10% | -58.76% |
| Change in Net Operating Assets | -363.76% | -359.13% | -161.69% | -148.05% | -103.84% |
| Cash from Operations | 1,007.87% | -39.78% | 141.90% | 77.85% | 94.78% |
| Capital Expenditure | 26.67% | 96.88% | -- | 100.00% | 98.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -936.24% | -466.05% | -33.94% | -81.15% | -92.86% |
| Cash from Investing | -955.81% | -488.65% | -14.98% | -79.74% | -92.29% |
| Total Debt Issued | 150.00% | 150.00% | 125.00% | -100.00% | -50.00% |
| Total Debt Repaid | -158.62% | -134.62% | -134.35% | 92.24% | 4.56% |
| Issuance of Common Stock | -- | -- | -- | 745.43% | 744.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 80.86% | 58.22% | 55.90% | -123.77% | 24.99% |
| Cash from Financing | -259.78% | -212.86% | -245.43% | 430.10% | 46.13% |
| Foreign Exchange rate Adjustments | -31.82% | -208.82% | -188.89% | 91.07% | 111.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -252.77% | -331.93% | -277.70% | 333.42% | 278.20% |